While we have gained preliminary understanding of the role of β3GNT9, future research should collect the tumor tissue samples of glioblastoma patients in the local hospital to further verify the impact of β3GNT9 expression on patients’ survival time. This evidence concerns the gene B3GNT9 and neoplasm.